RNA Quality in Post-mortem Human Brain Tissue Is Affected by Alzheimer's Disease.

ABSTRACT: Gene expression studies of human post-mortem brain tissue are useful for understanding the pathogenesis of neurodegenerative disease. These studies rely on the assumption that RNA quality is consistent between disease and neurologically normal cases; however, previous studies have suggested that RNA quality may be affected by neurodegenerative disease. Here, we compared RNA quality in human post-mortem brain tissue between neurologically normal cases (n = 14) and neurodegenerative disease cases (Alzheimer's disease n = 10; Parkinson's disease n = 11; and Huntington's disease n = 9) in regions affected by pathology and regions that are relatively devoid of pathology. We identified a statistically significant decrease in RNA integrity number (RIN) in Alzheimer's disease tissue relative to neurologically normal tissue (mixed effects model, p = 0.04). There were no statistically significant differences between neurologically normal cases and Parkinson's disease or Huntington's disease cases. Next, we investigated whether total RNA quality affected mRNA quantification, by correlating RIN with qPCR threshold cycle (C_T). C_T values for all six genes investigated were strongly correlated with RIN (p < 0.05, Pearson correlation); this effect was only partially mitigated by normalization to RPL30. Our results indicate that RNA quality is decreased in Alzheimer's disease tissue. We recommend that RIN should be considered when this tissue is used in gene expression analyses.

SUBMITTER: Highet B 

PROVIDER: S-EPMC8724529 | biostudies-literature |

REPOSITORIES: biostudies-literature